Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 Vioxx (Rofecoxib) Tablet & Oral Suspension
Company:  Merck & Co., Inc.
Application No.:  021042s017 & 021052s011
Approval Date: 05/19/2003


Date created: June 012006

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.